DOI: 10.12890/2020_001712

Inflammatory Myofibroblastic Tumour

Authors

  • Pedro Pimentel Duarte Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal
  • Rafaela Sousa Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal
  • Mariana Chaves Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal
  • Natacha Amaral Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal
  • César Lourenço Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal

pedropduarte@hotmail.com

Keywords

Abdominal pain, retroperitoneal space, neoplasm, inflammatory myofibroblastic tumour

Abstract

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal tumour. It is usually benign but may behave as a malignant tumour with multiple recurrences and metastases. We present the case of a young woman with weight loss associated with diffuse abdominal pain, who was shown to have a large pancreatic mass. Investigation revealed fusocellular mesenchymal neoplasia, compatible with the diagnosis of IMT. As the mass was unresectable, glucocorticoid therapy was initiated with an excellent response and regression of the tumour.

View the entire article

Downloads

Published

2020-06-16

Issue

Vol. 7 No. 9 (2020)

How to Cite

1.
Duarte PP, Sousa R, Chaves M, Amaral N, Lourenço C. Inflammatory Myofibroblastic Tumour. EJCRIM [Internet]. 2020 Jun. 16 [cited 2026 Nov. 3];7(9). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1712